ima
Uploaded by
26 SLIDES
487 VUES
260LIKES

Value of Pharmacy Services

DESCRIPTION

Value of Pharmacy Services. January 31 st (A), 2011 J. Hirsch, Ph.D. SSPPS – 207 Introduction to Health Care Systems and Policy. Value of Pharmacy Services What does the record show? Outcomes Clinical Economic Quality of Life. Therapeutic Outcomes. ETC…. Safety Outcomes.

1 / 26

Télécharger la présentation

Value of Pharmacy Services

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Playing audio...

  1. Value of Pharmacy Services January 31st (A), 2011 J. Hirsch, Ph.D. SSPPS – 207 Introduction to Health Care Systems and Policy

  2. Value of Pharmacy Services What does the record show? Outcomes Clinical Economic Quality of Life

  3. Therapeutic Outcomes ETC….

  4. Safety Outcomes

  5. Humanistic Outcomes

  6. Jadad Score: Indicates potential for bias in study design 1-5 (most to least bias potential); higher score better.

  7. Summary Results • Favorable results (vs. comparative services group) • Therapeutic and Safety outcomes (p<0.05) • HbA1c • LDL cholesterol • Blood pressure • Adverse drug events • Humanistic outcomes – more variability – yet SOME favorable (p<0.05) • Medication adherence • Patient knowledge • Quality of Life – not so much…..

  8. On WebCT under readings – but not a required reading. Only content (general results) relevant for Concept Quiz.

  9. Summary Economic Effects Pharmacists • Most economic studies were flawed • e.g. partial cost analyses, weak study design • 126 met criteria for review • 15.9% (n=20) positive results • 42.1% (n=53) mixed results • 4.8% (n=6) no effect • 37.3% (n=47) unclear effect • Positive studies mostly involved technical or multi-model interventions

  10. Economic Outcomes Economic Evaluations of Clinical Pharmacy Services: 2001-2005 Perez et.al., Pharmacotherapy 2008;28:286e-323e

  11. Economic Evaluations of Clinical Pharmacy Services: 2001-2005 • Literature Review • Update to previous ACCP review • Focused on Economic Outcomes • Excluded any with only clinical and humanistic outcomes • Results • 3,793 articles & abstracts 93 in final group, 15 in B/C

  12. Settings of Economic Evaluations of Clinical Pharmacy Services

  13. Type of Service or Intervention

  14. Benefit:Cost Ratios

  15. Conclusion “Based on the evidence examined in this review, clinical pharmacy services continue to provide a significant return on investment, but improvements are still needed in the methods used to evaluate the economic impact of these services.”

More Related